I really have no idea about our odds of success with FDA.
HDE is designed for rare illness with few or no options and cholangio is certainly that. And distal cholangio is reasonably similar to pancreatic ca.
But it would’ve helped to have done a few elsewhere.
I know OSL has good people working on the submission.
Maybe with tight entry criteria and post treatment surveillance they might get it through.
Thing is, it’s company making. If they get FDA for this it will be in the hands of US clinicians and the game is on.
- Forums
- ASX - By Stock
- Ann: Two more PANCOSIL Trial treatments using OncoSil device
I really have no idea about our odds of success with FDA. HDE is...
-
- There are more pages in this discussion • 220 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.001(7.69%) |
Mkt cap ! $23.78M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.6¢ | $34.37K | 5.002M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 4929003 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 23400459 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 4929003 | 0.006 |
25 | 18383399 | 0.005 |
33 | 24234949 | 0.004 |
9 | 11539965 | 0.003 |
6 | 5457516 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 23400459 | 26 |
0.008 | 13687076 | 12 |
0.009 | 14522573 | 8 |
0.010 | 7983000 | 7 |
0.012 | 10910 | 1 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |